PLAYSTATION 5 Titan Quest II launches January 19, 2027, ending Early Access with $49.99 PC price SOFTWARE AND UPDATES Neuralink N1 Implant Reconstructs ALS Patient’s Original Voice From Brainwaves ACCESSORIES Xiaomi Watch S5 Transparent Edition limited to 5,000 units at around $372 PHONES Rollme Matrix smartwatch launches with standalone 4G, 2.06-inch AMOLED display, and a pop-up camera for $89.99 NINTENDO SWITCH CKRD Atom+ keychain controller uses TMR sticks to eliminate drift for $30 GAMES Fan video suggests Grand Theft Auto VI map is significantly larger than Grand Theft Auto V PC HARDWARE Microsoft Surface Laptop 13-inch priced at around $1,511 with Snapdragon X2 PC HARDWARE Apple kills Mac mini storage upgrades with soldered NAND in M6 and M5 Pro models SOFTWARE AND UPDATES Microsoft Surface Pro 12-inch ‘Cabo’ to launch October 7 with Snapdragon X2 CONSOLES Nex Playground console launches at around $324 with built-in camera for body tracking GAMES Hell Let Loose Update 21 Introduces Conquest Mode With Morale Resource System VALVE Counter-Strike 2 update adds pet chickens players can hatch, raise, and collect GAMES Wardogs price jumps to $60 as developer enforces scaling cost model GAMES Roy Lee Developing New Silent Hill Film After Return to Silent Hill Flop

Neuralink N1 Implant Reconstructs ALS Patient’s Original Voice From Brainwaves

Owen Carter 0 comments 2 min read

Neuralink's N1 implant reconstructs an ALS patient's original voice from brainwaves, bypassing on- screen keyboards to aim for 140 words per minute.

Neuralink N1 Implant Reconstructs ALS Patient’s Original Voice From Brainwaves
SOFTWARE AND UPDATES

Neuralink has moved its brain-computer interface technology from text-based communication to full voice reconstruction, a shift that could restore natural conversation for patients with severe speech impairments. The company’s VOICE trial successfully translated the thoughts of ALS patient Kenneth Shock into speech, bypassing the slower on-screen keyboards used in earlier studies. This development matters because it targets the speed and naturalism required for daily interaction, aiming to match the pace of typical human dialogue rather than just typing commands.

Neuralink's VOICE trial translates ALS patient thoughts into natural speech

The N1 implant operates by targeting the speech motor cortex directly, reconstructing the patient's original voice from brainwave data without needing lip movements or throat sounds. Unlike the previous PRIME study trials, which relied on a cursor-based selection process, this system interprets neural signals associated with speaking. The technology effectively bypasses the intermediate step of text selection, allowing for a more fluid output that reflects the patient's intended vocalization.

Neuralink has implanted the N1 device in more than 20 patients globally, with two participants specifically enrolled in the VOICE trial. The system is designed to achieve a target speed of 140 words per minute, a benchmark set to facilitate natural conversation speeds. While the technology shows promise, the study has received FDA Breakthrough Device Designation, which classifies it as an investigational treatment rather than a commercially available solution.

The VOICE study represents a significant step in the clinical evaluation of neural interfaces for speech restoration. By focusing on the speech motor cortex, the N1 implant attempts to decode complex neural patterns into audible speech. The trial continues to monitor safety and efficacy as the company works to refine the accuracy and speed of the thought-to-speech translation for future applications.

Source: NotebookCheck

Related stories

Discussion

0 comments

Leave a comment